MediShield Life

Women welcome MOH move to screen for family cancer history, have insurance cover preventive surgery

Breast cancer is the most common cancer among women in Singapore, with more than 2,000 women diagnosed and more than 400 dying from the disease annually.

Branded Content

Reviewing your health insurance: MediShield Life, Integrated Shield Plans and IP riders explained

Mother reading to kids on couch

New IP rider premiums to cost at least 30% less, with one insurer offering an 84% reduction

New riders to be sold will differ in their coverage, with some covering up to public hospital stays and some up to private hospital stays.

AI and genetic screening, flexible use of MediSave to help super-aged S’pore stay healthy

Health Minister Ong Ye Kung brought up three new initiatives to support the changes in healthcare as Singapore readies itself for the future.

How will the new requirements for Integrated Shield Plan riders affect you?

New riders sold from April 2026 will have to impose the minimum deductibles that patients have to pay before insurance kicks in.

Insurers to let policyholders switch to new riders of similar, lower benefits without extra underwriting

Insurers will be facilitating transition of their policyholders to new riders without any additional underwriting.

MOH moves to curb rising premiums; IP riders sold from April 2026 won’t cover minimum deductibles

New riders on top of Integrated Shield Plans (IPs) to be sold from April 2026 can no longer cover the minimum IP deductibles, which means patients who are hospitalised, even if they do so for simple scans, will have to pay for hospitalisation costs themselves.

Six out of seven insurers raised premiums for Integrated Shield plans, riders in 2025

An Integrated Shield plan is optional health coverage provided by private insurance companies on top of MediShield Life.

People aged 40 and above can now redeem discounts of up to $580 to offset MediShield Life premiums

Participation in moderate to vigorous physical activity can earn one Healthpoints which could be used to offset MediShield Life premiums.

Second cell, tissue and gene therapy product for aggressive blood cancer now subsidised in Singapore

The use of axicabtagene ciloleucel (Yescarta) to treat a specific type of aggressive lymphoma is now supported with subsidies from the Ministry of Health.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.